Aptose Biosciences Inc. Files 8-K Report
Ticker: APTOF · Form: 8-K · Filed: Jun 17, 2025 · CIK: 882361
Sentiment: neutral
Topics: corporate-filing, 8-K
TL;DR
Aptose Biosciences filed an 8-K on 6/17/25 with corporate details.
AI Summary
On June 17, 2025, Aptose Biosciences Inc. filed an 8-K report. The filing indicates the company's jurisdiction of incorporation is Canada and provides its business and mailing address in Toronto. It also lists its SIC code as BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836].
Why It Matters
This 8-K filing provides essential corporate information and updates for Aptose Biosciences Inc., including its jurisdiction, address, and industry classification.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently poses a high risk.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
- Canada (jurisdiction) — State or Other Jurisdiction of Incorporation
- Toronto (location) — Business and Mailing Address City
- BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] (industry_code) — Standard Industrial Classification
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Aptose Biosciences Inc.
On what date was this 8-K report filed or is it effective?
The date of the report, and the date of the earliest event reported, is June 17, 2025.
What is the company's jurisdiction of incorporation?
The company's jurisdiction of incorporation is Canada.
What is the Standard Industrial Classification (SIC) code for Aptose Biosciences Inc.?
The SIC code is BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836].
What are the business and mailing addresses for Aptose Biosciences Inc.?
The business and mailing addresses are located at 66 Wellington Street West, Suite 5300, TD Bank Tower Box 48, Toronto, A6, M5K 1E6.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding Aptose Biosciences Inc. (APTOF).